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Background: Chemical insecticides against adult mosquitoes are a key element in most malaria management
programmes, but their efficacy is threatened by the evolution of insecticide-resistant mosquitoes. By killing only
older mosquitoes, entomopathogenic fungi can in principle significantly impact parasite transmission while
imposing much less selection for resistance. Here an assessment is made as to which of the wide range of possible
virulence characteristics for fungal biopesticides best realise this potential.
Methods: With mathematical models that capture relevant timings and survival probabilities within successive
feeding cycles, transmission and resistance-management metrics are used to compare susceptible and resistant
mosquitoes exposed to no intervention, to conventional instant-kill interventions, and to delayed-action
biopesticides with a wide range of virulence characteristics.
Results: Fungal biopesticides that generate high rates of mortality at around the time mosquitoes first become
able to transmit the malaria parasite offer potential for large reductions in transmission while imposing low fitness
costs. The best combinations of control and resistance management are generally accessed at high levels of
coverage. Strains which have high virulence in malaria-infected mosquitoes but lower virulence in malaria-free
mosquitoes offer the ultimate benefit in terms of minimizing selection pressure whilst maximizing impact on
transmission. Exploiting this phenotype should be a target for product development. For indoor residual spray
programmes, biopesticides may offer substantial advantages over the widely used pyrethroid-based insecticides.
Not only do fungal biopesticides provide substantial resistance management gains in the long term, they may also
provide greater reductions in transmission before resistance has evolved. This is because fungal spores do not have
contact irritancy, reducing the chances that a blood-fed mosquito can survive an encounter and thus live long
enough to transmit malaria.
Conclusions: Delayed-action products, such as fungal biopesticides, have the potential to achieve reductions in
transmission comparable with those achieved with existing instant-kill insecticides, and to sustain this control for
substantially longer once resistant alleles arise. Given the current insecticide resistance crisis, efforts should continue
to fully explore the operational feasibility of this alternative approach.* Correspondence: pennymath@lynch-fm.demon.co.uk
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The impressive reductions in global malaria burden
achieved this century by chemical insecticides against
adult mosquitoes could be eroded by insecticide-
resistant mosquitoes [1-6], just as they were last century
[7]. In principle, the evolution of insecticide resistance
could be considerably slowed and perhaps prevented
altogether by vector control aimed at killing only older
mosquitoes, so-called late-life action (LLA) [8]. Malaria
parasites in a mosquito host take at least nine days to
develop to a stage which can be transmitted to a human
via an infectious bite [9]. Since mortality in wild mos-
quito populations is high, the majority of eggs are pro-
duced by young mosquitoes. Thus, a vector-control
treatment which kills only older mosquitoes could re-
move infected mosquitoes before they can transmit mal-
aria whilst only impacting the reproductive success of
only the relatively few mosquitoes that survive to old
age. This would dramatically reduce transmission while
exerting only weak selection for resistance.
One option for an LLA vector-control measure is
entomopathogenic fungi [10]. Naturally occurring strains
of two fungi, Beauveria bassiana and Metarhizium
anisopliae, are already in commercial use for agricultural
applications and have been shown to infect and kill mos-
quitoes in laboratory and field settings. Fungal spores
can be picked up by mosquitoes following contact with
treated surfaces, and so could be used against mosqui-
toes in indoor residual spray (IRS) programmes, or deliv-
ered via traps, curtains or netting [11-16].
A wide variety of mortality schedules can be induced
in Anopheles by entomopathogenic fungi [17]. In some
cases, all mosquitoes can be killed within a few days; in
others, background mortality rates can be barely altered.
This virulence variation depends on isolate [11], dose
[18] and malaria-infection status [15,18], see also [19].
Lethality can also be increased by genetically modifying
fungal isolates [20-22].
If fungal entomopathogens are to realize the potential
of the LLA approach to sustainable malaria control, can-
didate biopesticides need to be chosen which balance
reductions in parasite transmission (maximized by high
fungal virulence) with resistance management (maxi-
mized by low fungal virulence). Here a mathematical
model is used to ask which virulence phenotypes best
achieve this balance. The intention is to guide the devel-
opment of target product profiles. The possible efficacy
of fungal biopesticides in IRS campaigns is compared
with that of pyrethroid-based insecticides now in wide-
spread use. Pyrethroids are highly lethal if contacted by
a mosquito, but they also have a strong excito-repellency
effect, which can drive away mosquitoes before they re-
ceive a lethal dose [23-25]. There is evidence that fungal
spores do not repel mosquitoes [26], raising the prospectthat, for IRS, fungal biopesticides might more effectively
reduce transmission than pyrethroid-based technologies
currently in use.
Methods
The model
Many malaria transmission models already exist [27],
but most do not capture the detailed timings and prob-
abilities of infection, infectiousness, reproduction and
mortality over the mosquito lifespan which are key to
assessing whether LLAs can provide a useful balance of
transmission control and low selection for resistance. In
order to encompass these elements, a model has been
developed with two separate components, a markovian,
deterministic, feeding cycle model (FCM) which calcu-
lates survival, egg-laying and infectious bite values dur-
ing the lifetime of an adult mosquito, and a population
model (PM) which tracks the population-level spread of
resistance alleles and corresponding loss of transmission
control. The model is a development of a simpler ver-
sion previously used to evaluate putative chemical LLAs
[8]. Other modelling frameworks used to assess the LLA
approach are heuristically useful but lack sufficient detail
to define target virulence schedules [28-30].
The feeding cycle model
The FCM calculates survival, egg-laying and infectious
bite values across a series of discrete adult age classes
for a specified type of mosquito (e.g., susceptible) sub-
jected to a given intervention (e.g., a particular fungal
biopesticide at a particular coverage). Each sequential
age class is defined as lasting for the average length of
one gonotrophic cycle. Use of the mosquito feeding
cycle as the basis for age-structured analyses of mos-
quito populations is well established [31-34].
The FCM tracks possible states and transitions
through each age class (i), applying survival, exposure
and infection probabilities (Figure 1). Infection status for
a biopesticide (l) or malaria (m), is zero for no infection,
otherwise equal to the age of the infection. State changes
depend on the preceding state, the passage of time, mor-
tality rates and the probabilities of certain events, such
as contacting a biopesticide when resting after a human
blood meal. For example, for a case analysing the effects
of a fungal biopesticide, a mosquito commencing its
fourth cycle with an infectious, three-cycle-old malaria
infection, and no fungal infection, will spend a defined
period of time searching for a host, with an associated
probability of dying from background mortality while it
does so. It will then attack a host, with a given probabil-
ity that the selected host will be a non-infectious human,
a malaria-infectious human, or non-human, and a given
probability of being killed whilst attacking the host be-
fore biting. If it survives to bite, and if the host is
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Figure 1 FCM model structure for one feeding cycle. Calculation of possible outcomes for feeding cycle i+1 of the model, assuming status
when commencing cycle i+1 is age = i, malaria status = mi, fungal infection status = li, with l0=0 and m0=0. Each arrow represents a probability
calculated by the model. If the malaria infection status (number of cycles since infection) of a mosquito when biting is greater than the
development time of the malaria parasite in the mosquito, then ‘bites host’ after attacking a human host is recorded as an infectious bite.
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then a given probability that it is killed by the host after
biting. If it is not killed, it begins a period of resting, dur-
ing which, if the chosen host was human, it has a fixed
probability of encountering and being infected by the
fungus, as well as a given probability of dying from back-
ground mortality before leaving to search for an egg-
laying site. During the search for an egg-laying site there
is a given probability that the mosquito may die from
background mortality, or from the effects of its newly
acquired fungal infection. If it survives searching for an
egg-laying site it may die before or after laying with
given probabilities. If still alive at the end of the cycle, itbegins its fifth cycle with an infectious, four-cycle-old
malaria infection, and a one-cycle-old fungal infection.
For a case analysing the effects of a conventional
instant-kill chemical pesticide, the analysis would in-
clude a probability of contacting the pesticide after bit-
ing the host, and a probability of death, assumed to be
instant, resulting from that contact, with zero probability
of contacting a biopesticide.
Both conventional instant-kill and delayed-action bio-
pesticides offer public health benefits by reducing the
numbers of mosquitoes that survive to give infectious
bites in a treated population. Clearly the extent to which a
reduction in infectious bites maps to reduced transmission
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human host population involves many complex, context-
specific factors. For comparative purposes, however, it is
assumed that in a given context, a given reduction in in-
fectious bites will generate the same reduction in malaria
transmission and malaria morbidity and mortality irre-
spective of the type of intervention from which it results.
For generality, therefore, the comparative public health
benefits of the insecticides considered in this analysis are
all evaluated based on the reduction in infectious bites
which they provide. This is quantified in the FCM for a
given phenotype by calculating RAIB, the proportionate
reduction in the average number of infectious bites per
mosquito per lifetime (AIB), defined as
RAIB ¼ 1 AIB with treatment
AIB without treatment
Assuming that the rate at which newly maturing adults
join a population is constant through time, and that the
size of the human host population is unaffected by the
intervention being assessed, RAIB is equal to the pro-
portionate reduction in the entomological inoculation
rate (EIR), the number of infectious bites experienced
per person per unit of time.
To evaluate mosquito fitness, the average number of eggs
produced per mosquito per lifetime is used as a proxy for
lifetime reproductive success (LRS). The selection coeffi-
cient, the proportionate fitness benefit of resistance to a
given intervention, is calculated as Selection Coefficient ¼
1 LRS for specified mosquito type with interventionLRS for susceptible mosquitoes without intervention
.
A selection coefficient of zero means no selection pressure
in favour of resistance, with higher selection coefficients in-
dicating increasingly strong selection for resistance.
Formulating these key variables in relative terms mini-
mizes the sensitivity of the conclusions to parameter
values that are independent of the vector-control treat-
ment or mosquito phenotype being evaluated.
The primary definitions of the FCM are given in
Table 1, and its main features are detailed below. A
detailed derivation of the FCM is given in Additional file
1: Appendix A. Baseline parameter values used in the
analysis are summarized in Table 2.
The probability that a mosquito contacts and is
affected (killed or infected) by a conventional or bio-
logical insecticide after biting a human host is input as a
single ‘coverage’ value, incorporating the probabilities of
being in a treated property, of contacting the pesticide,
and of being affected by the pesticide during contact. It
is assumed that physical constraints on the proportion
of surfaces and internal areas treated will apply equally
to conventional and fungal insecticides, and that for
mosquitoes contacting treated surfaces, biopesticidescan potentially offer rates of infection equivalent to the
rates of mortality generated by conventional insecticides.
The latter assumption is supported by field trials show-
ing >86% infection of mosquitoes entering outdoor bait
boxes [36], 76% infection in experimental huts with
fungus-impregnated eave curtains [13], and laboratory
trials showing >95% infection from treated clay pots [14]
or exposure to treated clay tiles [11].
The average number of eggs laid in a given cycle, by mos-
quitoes surviving to the start of that cycle, Fi, is calculated as
Fi ¼
Xi1
m¼0
Xi1
l¼0
fi;m;lvi;m;l
 !
Vi
This provides the basis for the evaluation of relative
fitness using a comparison of values for ϕ, lifetime egg
production, representing LRS, ϕ ¼
Xλ
i¼1
FiVi.
Comparative levels of transmission control are
assessed using u, the average number of infectious bites
per mosquito lifetime, u ¼
Xλ
i¼1
IiVi.
The average number of infectious bites during cycle i
per mosquito surviving to the beginning of cycle i, Ii, is
calculated as
Ii ¼
Xi1
m¼D
Xi1
l¼0
qi;m;l;2vi;m;l þ qi;m;l;3vi;m;l
Vi
i > D
The average probability of survival from start of cycle i
to start of cycle (i + 1) is Si, with
Si ¼
Xi1
m¼0
Xi1
l¼0
si;m;lvi;m;l
 !
Vi
The population model
The PM tracks susceptible and resistant phenotypes over a
sequence of time periods for a population subject to a given
vector-control treatment. The key outputs, calculated for
each time period, are the proportion of the population with
resistant and susceptible phenotypes and the overall reduc-
tion in infectious bites across the population compared to a
susceptible population with no vector-control treatment.
The variables and parameters for the PM are described
in Table 3, and baseline values used in the analysis are
summarized in Table 4.
A detailed derivation of the model is given in Additional
file 2: Appendix B. In brief, the PM works in discrete time
periods, each equivalent to the length of one gonotrophic
cycle, with recruitment of newly emerged adult mosquitoes
Table 1 Variables and parameters for the feeding cycle model
Variable or Parameter Symbol Comments and Constraints
Time, measured in whole units equal to average length of sporogonic cycle, from infection
of mosquito by malaria to cycle from which mosquito gives infectious bites
D input 0< D
Number of age classes included in analysis λ
Cycle number (identifies specific cycle in the λ cycles over which probabilities are tracked in the FCM) i 0≤ i ≤λ
Malaria status, the number of whole or partial cycles since infection with malaria m 0≤ m ≤λ, m = 0 means not infected
Biopesticide infection status, the number of whole or partial cycles since infection with biopesticide l 0≤ l≤ λ, l = 0 means not infected
Average number of eggs laid in cycle i by mosquitoes surviving to the start of cycle i Fi
Average lifetime number of eggs laid per mosquito ϕ
Average number of eggs laid in cycle i, by mosquitoes starting cycle i with malaria status m and
biopesticide status l
fi,m,l m<i l<i
Average probability of survival from start of cycle i to start of cycle i+1 Si
Average probability that a mosquito starting cycle i with malaria status m and biopesticide status l,
will survive to start of cycle i+1
si,m,l m<i l<i
Average probability of a mosquito being alive at start of cycle i. Vi
Average probability of a mosquito being alive, with malaria status m and biopesticide status l, at
start of period i.
vi,m,l m<i l<i
Probability that a mosquito alive at start of cycle i with malaria status m and biopesticide status l,
survives and bites host type h in cycle i
qi,m,l,h m<i l<i
Type of host attacked h h=1, non-human
h=2, non-infectious human
h=3, infectious human
Average number of infectious bites in cycle i per mosquito alive at the start of cycle i Ii
Average lifetime number of infectious bites per mosquito u
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each sequential time period, the proportion of the popula-
tion comprised by each genotype in each age class is calcu-
lated, reflecting the genotypes of new adult recruits and
the survival of adults in each age class from the preceding
period. This is then used to calculate the proportion of the
total population in time period n with homozygous reces-
sive (G3,n) and heterozygous (G2,n) genotypes, from which
Rn is calculated, the proportion of the population with a re-
sistant phenotype in period n, with Rn = G3,n + G2,nd.
Dominance is actioned by the value of d, which is 0 when
resistance is assumed recessive, and 1 when it is assumed
to be dominant.
Results from the FCM are used by the PM to calculate
the average number of infectious bites per mosquito
in the population during each time period. From this
Qn, the number of infectious bites given by the popula-
tion as a whole relative to those given by an untreated
population, can be calculated for each time period as
Qn ¼ MnWnJq .Assumptions
The model does not attempt to capture the effects of mu-
tational processes or stochastic demographic effects on
the origin and initial spread of very low numbers ofresistance alleles, and so it is assumed that resistant phe-
notypes are already established at a low frequency in the
population at the start of the analysis. Resistance involves
a single gene and a simple dominant/recessive process.
Moreover, it is assumed that the size and age structure of
the population at the start of the PM analysis is that
achieved after sustained use in a susceptible population of
the insecticide being evaluated, that there is no immigra-
tion or emigration, and the proportion of each genotype
in the new adults joining the population matches that in
the eggs from which they originate. Density dependence is
assumed to occur at the mosquito larval stage and the
number of adult mosquitoes recruited to the population
per unit of time remains constant.
All model parameters are age-independent, apart from
background mortality rates and the action of age-linked
pesticides, with incremental mortality from fungal bio-
pesticide infection varying according to the number of
days since infection. Conventional insecticides affecting
a susceptible individual are assumed to be instantly fatal.
Mosquitoes choose human hosts at random, and the
model does not capture feedback between numbers of
infectious bites and the proportion of human hosts with
infectious malaria. Malaria-infected mosquitoes never
become uninfected. All feeding cycles are of equal dur-
ation and mosquitoes bite once in each cycle. All eggs
Table 2 Values used in FCM for this analysis
Variable or Parameter Symbol Value units
Background instantaneous mortality rate for mosquito age i rB,i 11.75%
1 per day
Length of gonotrophic cycle w 2.85 1 days
Time spent host searching and feeding during a cycle b 1.26 5 days
Time spent finding oviposition site and laying during a cycle ϕ 1.26 5 days
Length of resting period (days) η 0.32 5 days
Proportion human population infectious for malaria4 p 4.28% 1
Probability attacks non-human host H 0.17 1
Probability killed when attacking host before biting a1 .05
6
Probability killed when attacking host after biting (excluding mortality from
insecticide treatments)
a2 .05
6
Probability becomes infected with malaria when biting infectious human host4 M 1.00
Number of eggs laid per successfully laying mosquito per cycle L 100 2 eggs
Time, measured in whole units equal to length of gonotrophic cycle, from
infection of mosquito to cycle from which mosquito gives infectious bites
D 3 3 Based on 10.78 1 days cycles
Baseline probability that mosquito contacts and is killed by conventional instant-kill
chemical insecticide (CC) whilst resting after biting human host
k 0 for cases not assessing use of CC
0.8 for cases assessing use of CC
Baseline probability that mosquito contacts and is affected by delayed action
pesticide whilst resting after biting human host
X 0 for cases not assessing use of
delayed action pesticide
0.8 for cases assessing use of delayed
action pesticide
Number of age classes included in analysis λ 10 cycles
1.Averages taken from four geographic locations [31]. Results using individual geographic data sets are expected to give qualitatively equivalent results. Limited
sensitivity analysis was consistent with this assumption, so use of the average figures was considered adequate for the present analysis.
2.Since we are only interested in comparative values, the absolute value for the number of eggs per lay is immaterial, 100 has been used as a convenient normalised
value.
3.The number of cycles assumed for sporogonic development is calculated from the average number of days for sporogonic development and the average number of
days per gonotrophic cycle, rounded down to give a whole number of cycles. This is a conservative assumption with respect to the amount of EIR reduction calculated
for given fungal virulence parameters.
4.The data set used provides a total probability of acquiring a malaria infection when biting a human host. This has been used as the value for parameter p, with
M=1.00, to give the appropriate combined probability, Mp.
5. Assumes c.11.1% of every cycle is spent resting (8 hours in a 72 hour cycle), with the rest of the gonotrophic cycle divided equally between laying and feeding.
6. Estimated 10% mortality per feeding attempt [35], divided equally between pre- and post-bite.
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that malaria infection produces no effects on behaviour,
background mortality or fecundity in infected mosquitoes,
and fungus-infected mosquitoes that survive and lay eggs
are assumed to lay as many eggs at each laying event as
uninfected individuals.
Mosquitoes are assumed to contact the chemical or
biopesticide when resting after biting a human host,
reflecting an application method essentially consistent
with IRS. Avoidance behaviour such as outdoor feeding
and outdoor resting is not reflected in the coverage
values for susceptible mosquitoes since it comprises a
method of resistance.Analysis
A number of fungal strains have now been tested in la-
boratory mosquito populations, and a wide range of
mortality characteristics have been observed around the
basic pattern of initial fungal growth and development
followed by an increase in observable mosquitomortality [11,15,16,18,37]. This suggests that most viru-
lence profiles are potentially available, and in a search
for generalizable results this analysis therefore uses
highly simplified virulence mortality characteristics,
defined by two parameters, ‘initiation day’, the time from
infection to the onset of fungus-induced mortality, and
the daily mortality rate from that point (Figure 2).
Fungal biopesticides can also impact mosquito feeding
propensity and flight capacity in the days before mos-
quito death [11]. A mosquito which no longer attempts
to feed or to lay eggs is effectively dead from the per-
spectives of fitness and disease transmission. For the
purpose of the model therefore, ‘mortality’ encompasses
cessation of feeding and reproduction, as well as actual
death.Results
Coverage and virulence
The proportionate reduction in EIR generated by use of a
biopesticide is affected by fungal virulence and coverage
Table 3 Variables and parameters for the population model
Variable or Parameter Symbol Comments &
Constraints
Period number (periods over which the population is tracked)* n 0<n
Dominance of resistance allele d dominant d = 1
recessive d = 0
Genotype (normal allele s, resistant allele r) g (s,s) g = 1
(s,r) g = 2
(r,r) g = 3
Proportion of total population having genotype g at start of period n Gg,n
Proportion of the population resistant at start of period n Rn
Average number of infectious bites per mosquito in population in period n Mn
Size of initial population (susceptibles in the presence of treatment) as proportion of base population (susceptibles
without treatment)
J value from FCM
Population size in period n as proportion of initial population size Wn
Average infectious bites during one time period from an untreated population q value from FCM
Number of infectious bites from treated population during time period n, expressed as a % of the number of
infectious bites during one time period from a susceptible population without treatment,
Qn Chosen measure of
control
Number of periods between egg-laying and adult emergence Φ Input
*As for the FCM, the duration of one gonotrophic cycle is used as a unit of time. For convenience we use ‘cycles’ to refer to mosquito age and ‘periods’ to refer to the
sequential time periods for which values are calculated in the PM.
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EIR reduction are achieved by various combinations of the
two parameters used to summarize virulence (initiation
day and mortality rate (Figure 2)). Unsurprisingly, the
longer a fungus takes to initiate mortality, the greater the
subsequent mortality rate has to be to maintain a given
level of reduction in EIR. There are limits to the EIR
reductions that can be achieved at low virulence and/or
low coverage.
For equivalent reductions in EIR, selection for resist-
ance is best minimized by high coverage with late initi-
ation day, high mortality rate biopesticides. For example,
the lowest selection coefficient associated with a 90%
RAIB at 80% coverage is 21%, with day 9 initiation and
a 91% mortality rate. At 50% coverage the lowest selec-
tion coefficient available in combination with 90% RAIB
is 40%.Table 4 Values used in the population model for this
analysis
Variable or Parameter Symbol Value
Proportion of total population
having genotype g at start
of period 1
Gg,1 G1,1 = 1-G2,1
G2,1 = 10
-9
G3,1 = 0
Dominance of resistance allele
(0=recessive, 1=dominant)
d d = 1
Number of periods between egg-laying
and adult emergence
Φ 3
Fitness factor for males with genotype g fg f1=f2=f3=1.00
All other input values use results calculated by the FCM.The temporal dynamics of EIR reduction and resist-
ance evolution are shown in Figure 4. Predictably, more
virulent biopesticides give better population-level reduc-
tions in EIR to begin with, but they then drive the evolu-
tion of resistance more rapidly. The speed of resistance
evolution is more sensitive to the timing of mortality
onset than to the incremental mortality rate.
The evolutionary dynamics and resulting pattern of
control failure differ markedly for different insecticides
even when they give identical reductions in EIR in the
pre-evolutionary phase (Figure 5). Conventional instant-
kill chemical insecticide (with coverage adjusted to
achieve the same initial control) fails first. The longest
time to product failure is offered by a fungal biopesticide
with relatively late mortality initiation, which then kills
at a very high rate (Figure 5).
Clearly, the probability that a mosquito contacts and
is affected by a vector-control treatment has a significant
impact on both the reduction in EIR and reproductive
success. Reductions in EIR improve as coverage is
increased, but the strength of selection for resistance
also increases (Figure 6, left panels). This illustrates
the predictable trade-off between the best transmission
control, obtained at high coverage, and the best resist-
ance management, obtained at low coverage. When
compared to the currently available alternative, a con-
ventional instant-kill chemical insecticide, however, the
relative values for EIR reduction and resistance manage-
ment with the biopesticides are maximized at the high
coverage values which correspond to the best transmis-
sion control and the strongest selection pressures for
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Figure 2 Illustrative survival curves for a range of simple virulence mortality assumptions. Survival curves illustrating mortalities defined by
two simple virulence parameters. For each illustrated pair of values, mortality is zero until the specified initiation day, and is thereafter maintained
at the indicated fixed daily mortality rate. Initiation day and mortality rate are the two parameters used to define the assumed incremental
mortality generated by a given biopesticide infection.
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with sufficiently high virulence to match the initial
EIR reduction of instant-kill insecticides at the same
coverage levels offers some benefit in terms of useful(i)
(i) (ii) (iii)
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proportion of resistant individuals (bottom panel) and the percentage redu
population consistently exposed to one of four vector control treatments,life (Figure 7). This is because fungus-infected mosqui-
toes are still able to achieve some reproduction before
being killed, thus somewhat reducing the selection
for resistance.(iv)
(iv)
Coverage Initiation   mortality
(i) 44%               instant kill  
(ii) 50% day 3          53%
(iii) 80% day 3          22%
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e
uction in infectious bites. Plots show the change over time in the
ction in population level infectious bites (top panel) for a mosquito
all chosen to give the same 90% initial reduction in EIR.
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Figure 6 Comparison of conventional instant-kill chemical insecticide and four biopesticides across a range of coverage values.
Lifetime reproductive success with interventions as a proportion of LRS for untreated mosquitoes (top left panel) and as a proportion of LRS for
mosquitoes treated with an instant-kill insecticide (top right panel). Reduction in average infectious bites per mosquito lifetime with interventions,
compared to the value for untreated mosquitoes (bottom left panel), 0 = no reduction in infectious bites, 1.00 = no infectious bites. Reduction in
infectious bites with interventions vs untreated mosquitoes, compared to the reduction achieved using a conventional instant kill insecticide
(bottom right panel), 1.00 means reduction equal to that achieved by instant-kill insecticide.
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One of the most commonly used classes of conventional
insecticides, pyrethroids, have high contact irritancy
(also called excito-repellency), causing approximately
50% of mosquitoes contacting treated surfaces to be re-
pelled without acquiring a harmful dose [23-25,38].
There is no indication of any repellency effects for the
fungal biopesticides [26]. For IRS, if 50% of mosquitoes
contacting the instant-kill insecticide are unaffected by
it, then, for equivalent spray coverage, fungal biopesti-
cides offer better reductions in EIR at all coverage levels,
whilst maintaining selection benefits for all but the most
virulent strain at the lowest coverage (Figure 8).
Malaria interactions
Some fungal strains have been shown to have higher viru-
lence in malaria-infected mosquitoes than in those without
malaria infection [15]. The trade-off between reducing EIR
and resistance management is greatly reduced where fungal
virulence is lower in malaria-free mosquitoes, with selection
for resistance virtually eliminated if the fungus induces mor-
tality exclusively in malaria-infected mosquitoes (Figure 9).
Discussion
Variation in the virulence characteristics of potential bio-
pesticides offers scope for selecting strains targeted toprovide desirable combinations of reduced transmission
and resistance management. A number of virulence phe-
notypes can provide equivalent levels of EIR reduction
(Figure 3), and in general high biopesticide-induced mor-
tality rates commencing as late as possible offer better re-
sistance management for a given level of EIR reduction
(Figures 3 and 5). There is nonetheless a trade-off between
extending the time taken for resistance evolution to
undermine efficacy of a pesticide, and the initial reduc-
tions in transmission (Figure 4). In general terms, more
virulent fungal strains better reduce transmission initially,
but at the cost of stronger selection for resistance, and
consequently a shorter useful life (Figure 10).
Although high coverage offers scope to use less viru-
lent fungal strains to reduce EIR, for given virulence
parameters, higher levels of coverage also generate
stronger selection for resistance, for both conventional
and biopesticide interventions. Remembering that the
biopesticides must be considered in relation to the best
currently used approaches, it is interesting to note that
in relative terms, the benefits of biopesticides versus
conventional instant-kill insecticides are maximized at
high coverage for both transmission control and resist-
ance management (Figure 6).
The relative importance of initial control versus prod-
uct lifespan depends on a large number of factors,
time
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Figure 7 Comparison of resistance spread and consequent increases in infectious bites with instant-kill and fungal biopesticides.
Biopesticide virulence selected to give pre-resistance EIR reduction matching instant-kill pesticides at 80% or 30% coverage. Plots show the
proportion of the population with resistant phenotypes, and the corresponding values for population-level reduction in infectious bites per unit
of time compared to an untreated population.
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Figure 8 Comparison between biopesticides and instant-kill insecticide with 50% contact irritancy, across range of coverage values.
Lifetime reproductive success with interventions as a proportion of LRS for untreated mosquitoes (top left panel) and as a proportion of LRS for mosquitoes
treated with an instant-kill insecticide with 50% contact irritancy (top right panel). Reduction in average infectious bites per mosquito lifetimewith
interventions, compared to the value for untreated mosquitoes (bottom left panel), 0 = no reduction in infectious bites, 1.00 = no infectious bites.
Reduction in infectious bites with interventions vs untreated mosquitoes, compared to the reduction achieved using a conventional instant kill insecticide
with 50% contact irritancy (bottom right panel), 1.00 means reduction in AIB equal to that achieved by instant-kill insecticide with 50% contact irritancy.
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Figure 9 Differential mortality in malaria-infected and malaria-free mosquitoes. Comparison of speed of spread of resistance and
consequent loss of transmission control for populations treated with one of five fungal biopesticides with differential mortality rates in malaria-
infected mosquitoes. Plots show the proportion of the population with resistant phenotypes, and the corresponding values for population-level
reductions in infectious bites per unit of time compared to an untreated population. The biopesticides all have day 3 initiation of a 72% daily
mortality rate for malaria infected mosquitoes, giving an initial 99% reduction in infectious bites per time period.
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treatments, the meaning in terms of human morbidity
and mortality of a smaller reduction in EIR at the outset,
and the realities of public budgets and other resources.
The relative costs and benefits also change if the biopes-
ticide is being considered for use as part of a combin-
ation treatment with other interventions [34,39,40].
There is, therefore, no simple mathematical optimum
for the many possible virulence schedules; the many
possibilities need to be considered in context. In so far
as it can be done without compromising transmissiontime
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Figure 10 Schematic illustration of the trade-off between initial levels
highlight the differences in infectious bites resulting from a choice betwee
reduction and high selection for resistance versus a lower-virulence interve
red area highlights the additional infectious bites associated with choosing
shows the additional infectious bites associated with choosing the high-vircontrol, however, it is clearly beneficial to choose the
biopesticide that generates the lowest selection for re-
sistance in a particular context. For resistance manage-
ment, the aim should be to achieve high levels of
coverage, allowing less virulent fungal strains to achieve
a given level of control, and maximizing their resistance
management benefits over instant-kill insecticides.
Even strains sufficiently virulent to match the transmission-
reducing characteristics of conventional instant-kill chemical
insecticides at matching coverage levels still offer a small
benefit in terms of the rate of spread of resistance (Figure 7).Cost of using 
less virulent 
strain
Benefit of 
using less 
virulent 
strain
of control and product useful life. The green and red areas
n a high-virulence intervention with high initial infectious bite
ntion with lower initial benefits and lower selection for resistance. The
the lower virulence option, before resistance spreads. The green area
ulence option in the long term once resistance spreads.
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http://www.malariajournal.com/content/11/1/383Such a resistance management gain would be enhanced by
any fitness costs associated with resistance [8].
The conclusions presented here are independent of
the method of resistance (e.g., metabolic or behavioural),
provided resistance is genetically determined. It is
assumed however that resistance is a binary quality, with
mosquitoes either experiencing the full effects of a con-
trol measure, or remaining completely unaffected by it.
The analysis of the speed of spread of resistance here
thus assumes that susceptible mosquitoes experience
infections with the specified virulence characteristics,
and that resistant mosquitoes have no fungal mortality.
In reality, it is more probable that a resistance/tolerance
process would operate, with resistant mosquitoes still
becoming infected, but experiencing a lower mortality
rate than fully susceptible individuals. The spread of re-
sistance would therefore effectively comprise a reduction
in fungal virulence, rather than a complete loss of con-
trol. Considering the results presented in Figure 4, for
example, this would mean that the spread of resistance
to the highest virulence biopesticides, rather than com-
prising a steep function to complete resistance and total
loss of transmission control, would move to the curves
calculated for sequentially less virulent strains, as resist-
ance converts high virulence strains to low virulence
strains, offering even more beneficial resistance manage-
ment possibilities. Future analyses could explore the im-
pact of hypothetical resistance mechanisms that might
operate with respect to conventional and fungal pesti-
cides. The analyses presented here could also be
extended to evaluate the impact of malaria infection on
mosquito survival, fecundity and behaviour and variation
in fecundity with mosquito age.
Certain widely used pyrethroid insecticides have high
contact repellency, with studies suggesting that around
50% of mosquitoes landing on treated surfaces may leave
before acquiring a fatal dose [23-25,38]. Whilst this po-
tentially enhances the impact of pyrethroid-treated bed
nets on transmission by deflecting mosquitoes away
from protected humans before they bite, for IRS it
results in mosquitoes surviving to potentially transmit
malaria in later feeding cycles [24]. Thus, for this group
of conventional insecticides, the composite ‘coverage’
value at a given level of spray cover, would be half that
for biopesticides, and could never be greater than 50%.
Comparing biopesticide performance with that of a con-
ventional insecticide, and assuming 50% contact repel-
lency (Figure 8) across a full range of coverage values,
fungi better reduce transmission than pyrethroid IRS,
while still maintaining some resistance management
benefits. This suggests that, for all spray coverage values,
suitably virulent fungal strains might provide a better
option for IRS-based vector interventions than contact-
repellent pyrethroids. If only low levels of spray coverageare achievable, replacing repellent pyrethroids with high-
virulence fungal treatments could significantly improve
the achievable EIR reduction, without significantly in-
creasing selection for resistance, which is in any case
relatively weak at low coverage (Figure 8). Where high
spray coverage is achievable, replacing pyrethroids with
relatively low-virulence fungal treatments could give
improvements in both transmission control and resist-
ance management, since the relative fitness of suscep-
tible mosquitoes would be potentially doubled.
The analysis shows that in all cases, having higher
fungal-induced mortality in malaria-infected mosquitoes
than in uninfected mosquitoes minimizes the fitness
costs associated with a given reduction in transmission
(Figure 9). The ideal biopesticide from the resistance
management perspective would be one that had little or
no impact on mosquitoes not infected with malaria, but
was strongly virulent in malaria-infected individuals.
This might be possible since malaria infection can im-
pose significant metabolic and immunological challenges
to mosquitoes [41-44]. There is only a minimal trade-off
between transmission control and resistance manage-
ment in malaria-linked incremental biopesticide mortal-
ity. By changing the fitness cost to the mosquito of
malaria infection, pesticides working in this way might
also exert selection in favour of vector resistance to mal-
aria, further enhancing the transmission-control benefits
from the intervention. Strain selection or genetic modifi-
cation should ideally target this trait. A further develop-
ment of this principle would be fungal strains which
specifically block development of the malaria parasite in
the mosquito, or simply act as a delivery mechanism for
anti-malaria interventions in the mosquito host (‘para-
transgenesis’ [10,37]), with minimum survival or fecund-
ity costs to the mosquito. It must be noted, however,
that this potentially moves selection for resistance from
the mosquito to the malaria parasite, which has so far
proved extraordinarily adept at evolving its way out of
trouble.
Conclusions
This analysis shows that fungal biopesticides have the
potential to significantly reduce EIR while imposing only
weak selection for resistance. There is always a trade-off
between the magnitude of the initial reductions in trans-
mission and maintaining those reductions in the longer
term. Given the severe human and economic conse-
quences of malaria transmission, choosing an interven-
tion which does not maximally reduce transmission at
the outset requires very careful justification. However,
the analyses presented here show that fungal biopesti-
cides can offer equivalent or better reductions in trans-
mission than existing interventions in both the short
and long term. This is especially true where existing
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tancy or resistance to them has already begun to spread.
The theoretical analyses presented here should help define
the vector mortality profiles required to maximize the sus-
tained malaria control potential of fungal biopesticides, or
indeed other novel biological or chemical insecticides.
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Appendix A 
 
Derivation of the Feeding Cycle Model 
The primary definitions for the FCM are given in the main text and Table 1. Full supporting 
details are given below and in Table 5. 
 
The average number of eggs laid in cycle i, by mosquitoes starting cycle i with malaria status m 
and biopesticide status l is defined as 
3
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The average probability of an adult mosquito surviving to the start of cycle i, Vi , is 1 for cycle 
1. For all subsequent cycles, Vi is the sum for all possible combinations of fungus & malaria 
status of the probabilities of an adult mosquito surviving to the start of cycle i.  
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The various survival probabilities, , ,i m lv  are calculated as follows. The average probability of an 
adult mosquito surviving to the start of cycle i, and being in the mth cycle of malaria infection 
and the lth cycle of fungus infection at the start of cycle i, vi,m,l, is 1.00 at the start of cycle 1, 
and thereafter calculated for each possible combination of m and l at the start of the preceding 
cycle. 
1,0,0 1.00v   
The probability of surviving to the start of cycle i with no malaria or biopesticide infection, 
,0,0iv , is the probability of surviving, uninfected, to the start of the previous cycle, and then 
surviving biting a non-human host, or biting a human host without being infected by malaria or 
biopesticide, and then surviving through laying. 
     ,0,0 1,0,0 1,0,0,1 1,0,0,2 1,0,0,3 1 1,01 1 1 Ci i i i i i iv v q q q M k X z                 i > 1 
The probability of surviving to the start of cycle i with newly acquired infections for malaria 
and biopesticide, ,1,1iv , is the probability of surviving, uninfected, to the start of the previous 
cycle, and then surviving biting an infectious human host, becoming infected with malaria and 
a biopesticide, and then surviving through laying, without being killed by any rapid 
biopesticide mortality.  ,1,1 1,0,0 1,0,0,3 1 1,01  zAi i i i iv v q k MX             i > 1 
The probability of surviving to the start of cycle i with a newly acquired malaria infection, and 
no new biopesticide infection, ,1,0iv , is the probability of surviving, uninfected, to the start of 
the previous cycle, and then surviving biting an infectious human host and becoming infected 
by malaria, not acquiring a biopesticide infection, and then surviving through laying.   ,1,0 1,0,0 1,0,0,3 1 1,01 1 Ci i i i iv v q M k X z              i > 1 
The probability of surviving to the start of cycle i with a newly acquired malaria infection, and 
an existing biopesticide infection, ,1,i lv  is the probability of surviving, with a biopesticide 
infection, but no malaria infection, to the start of the previous cycle, and then surviving biting 
an infectious human host and becoming infected by malaria and then surviving through laying, 
with survival probabilities reflecting additional mortality from the biopesticide infection.  ,1, 1,0, 1 1,0, 1,3 1 1,0, 11  i l i l i l i i lv v q k M z              i > 1  l > 1 
The probability of surviving to the start of cycle i with an existing malaria infection, and no 
biopesticide infection, , ,0i mv , is the probability of surviving, with a malaria infection but no 
biopesticide infection, to the start of the previous cycle, and then surviving biting a non-human 
host or biting a human host without becoming infected by a biopesticide, and then surviving 
through laying.     , ,0 1, 1,0 1, 1,0,1 1, 1,0,2 1, 1,0,3 1 1, 11 1 Ci m i m i m i m i m i i mv v q q q k X z                       
       i > 1 m >1 
The probability of surviving to the start of cycle i with no malaria infection, and a newly 
acquired biopesticide infection, ,0,1iv , is the probability of surviving, with no malaria or 
biopesticide infection, to the start of the previous cycle, and then surviving biting a human host, 
not acquiring a malaria infection and becoming infected by a biopesticide, and then surviving 
through laying, without being killed by any rapid biopesticide mortality. 
   ,0,1 1,0,0 1,0,0,2 1,0,0,3 1 1,01 1 Ai i i i i iv v q q M k Xz          i > 1 
The probability of surviving to the start of cycle i with an existing malaria infection, and a 
newly acquired biopesticide infection, , ,i m lv , is the probability of surviving, with a malaria 
infection but no biopesticide infection, to the start of the previous cycle, surviving biting a 
human host and becoming infected by a biopesticide, and then surviving through laying, 
without being killed by any rapid biopesticide mortality.   , ,1 1, 1,0 1, 1,0,2 1, 1,0,3 1 1, 11  Ai m i m i m i m i i mv v q q k X z                  i > 1   m > 1 
The probability of surviving to the start of cycle i with no malaria infection, and an existing 
biopesticide infection, ,0,i lv , is the probability of surviving, with no malaria infection and an 
existing biopesticide infection, to the start of the previous cycle, and then surviving biting a 
non-human host or biting a human host without acquiring a malaria infection, then surviving 
through laying, with survival probabilities reflecting additional mortality from the biopesticide 
infection. 
    ,0, 1,0, 1 1,0, 1,1 1,0, 1,2 1,0, 1,3 1 1,0, 11 1i l i l i l i l i l i i lv v q q q M k z                  i > 1   l > 1 
The probability of surviving to the start of cycle i with existing malaria and biopesticide 
infections, , ,i m lv , is the probability of surviving, with existing malaria and biopesticide 
infections, to the start of the previous cycle, surviving biting any host, then surviving through 
laying, with survival probabilities reflecting additional mortality from the biopesticide 
infection.    , , 1, 1, 1 1, 1, 1,1 1, 1, 1,2 1, 1, 1,3 1 1, 1, 11i ml i m l i m l i m l i m l i i m lv v q q q k z                      i > 1   m > 1  l > 1 
The probabilities of surviving through cycle i are calculated as follows. The average 
probability, , ,i m ls , that mosquitoes starting cycle i with any malaria status and an existing 
biopesticide infection, will survive to the start of cycle i + 1 is calculated as the probability of 
surviving biting a non-human host, plus the probability of biting a human host without being 
killed by conventional instant-kill insecticides, and then surviving to lay. 
  3, , , , , , , ,1 , ,
2
1i m l i i m l h i m l i m l
h
s k q q z

              l > 0 
 
The average probability, , ,0i ms , that mosquitoes starting cycle i with any malaria status and no 
biopesticide infection, will survive to the start of cycle i + 1 is calculated as the probability of 
surviving biting a non-human host, plus the probability of biting a human host without being 
killed by conventional instant-kill insecticides, and then either not acquiring a biopesticide 
infection, or acquiring a biopesticide infection but not being killed by the biopesticide before 
the end of the cycle, and then surviving to lay. 
    3, ,0 , , , ,  , , , ,1 .
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h
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
            i < λ   
 
The probabilities of surviving host seeking and biting in cycle i, , , ,i m l hq , are calculated as 
follows. The probability, , , ,1i m lq  that a mosquito starting cycle i with malaria status m, and 
biopesticide status l, survives seeking and biting a non-human host, is the proportion of non-
human hosts multiplied by the probability of surviving background mortality and the effects of 
any biopesticide infection whilst host seeking, and successfully biting without being killed 
whilst attacking host.    1,( ), , ,1 , , 11 1i mb ri m l i m lq H e a       . 
 
The probability, , , ,2i m lq , that a mosquito starting cycle i with malaria status m, and biopesticide 
status l, survives seeking and biting a human host not infectious for malaria is the proportion of 
hosts which are human and not infectious for malaria, multiplied by the probability of surviving 
background mortality and the effects of any biopesticide infection whilst host-seeking, and 
successfully biting without being killed whilst attacking host is 
     1,( ), , ,2 , , 11 1 1 1i mb ri m l i m lq p H e a        
. 
 
The probability, , , ,3i m lq , that a mosquito starting cycle i with malaria status m, and biopesticide 
status l, survives seeking and biting a human host infectious for malaria is the proportion of 
hosts which are human and infectious for malaria, multiplied by the probability of surviving 
background mortality and the effects of any biopesticide infection whilst host seeking, and 
successfully biting without being killed whilst attacking host is 
    1,( ), , ,3 , , 11 1 1i mb ri m l i m lq p H e a        . 
The probabilities, , ,i m lz   that a mosquito starting cycle i with infection status m,l, will survive 
site seeking and lay eggs are calculated as follows.  
 
    3, 2, ( )( ) 0, , 2 , ,1 1    i i mr r li m l i m lz a e                
 
Probability, ,
A
i mz  that a mosquito starting cycle i with no fungal infection, having survived 
biting a host, will survive site seeking and lay eggs if it acquires a new fungal infection during 
cycle i  is 
    3, 2, ( )( ), 2 , ,01 1 i i mr rAi m i mz a e              . 
Probability, ,
C
i mz  that a mosquito starting cycle i with no fungal infection will survive site 
seeking and lay eggs if it does not acquire a new fungal infection is 
   3, 2, ( )( ), 21 i i mr rCi mz a e            . 
 
The probabilities, , ,i m l , of dying from the effects of the biopesticide whilst host seeking in 
cycle i, for a mosquito starting cycle i with infection status m, l, are calculated as; 
, ,0 0i m   
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The probability, , ,i m l , of dying from the action of the biopesticide between biting and laying 
during cycle i, having started the cycle with infection status m,l is calculated for mosquitoes 
which are already infected with fungus at the start of cycle i, or which become newly infected 
during cycle i, as follows; 
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For mosquitoes newly infected during cycle i, the probabilities, , ,0i m , of dying from the effects 
of the biopesticide before the end of the cycle are, 
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Table 5 Additional variables and parameters of the FCM 
 
Variable or Parameter 
 
 
Symbol 
 Comments 
and 
Constraints 
Base instantaneous mortality rate per day for mosquito age i during activity B  rB,i input 
Length of gonotrophic cycle (days) w input 
Time spent host searching and feeding during a cycle  (days) b input 
Time spent finding oviposition site and laying during a cycle (days)  input 
Length of resting period (days)  input 
Time required for parasite sporogonic development (days) d input 
Proportion human population infectious for malaria p input 
Probability attacks non-human host H input 
Probability killed when attacking host before biting a1 input 
Probability killed when attacking host after biting (excluding mortality from 
insecticide treatments) 
a2 input 
Probability contacts and contracts biopesticide infection whilst resting after biting 
human host (biopesticide ‘coverage’) 
X input 
0 in cases not 
assuming use of 
biopesticide 
Probability becomes infected with malaria when biting infectious human host M input 
Probability contacts and is killed by instant action conventional insecticide when 
attacking human host, after biting (conventional chemo ‘coverage’) 
ki input 
0 in cases not 
assuming use of 
conventional 
insecticide 
Normalised number of eggs laid per successfully laying mosquito per cycle L input 
 
Malaria-fecundity adjustment factor, proportionate number of eggs produced by 
mosquitoes with malaria infection age m  
E1,m input 
 
Biopesticide-fecundity adjustment factor, proportionate number of eggs produced 
by mosquitoes with biopesticide infection age l  
E2,l input 
 
Probability that a mosquito alive at start of cycle i with malaria status m and 
biopesticide status l, having survived to bite, then survives to lay eggs 
zi,m,l, m<i   l<i 
Instantaneous daily mortality rate from biopesticide on nth day after infection, for 
mosquitoes with no malaria infection 
n input 
 
Instantaneous per day mortality rate from biopesticide on nth day after infection, 
for mosquitoes with malaria infection 
n input 
 
Incremental daily mortality rate with malaria infection age m m input 
Incremental daily mortality rate assumed as cost of resistance*  input 
% reduction in egg production assumed as cost of resistance*  input 
Activity type, searching for host, resting, searching for laying site B host-seeking = 1 
resting = 2 
site-seeking = 3 
Probability of dying from action of biopesticide before biting host in cycle i, for 
mosquito starting cycle i with malaria status m and biopesticide status l 
i,m,l  
Probability of dying from action of biopesticide between biting host and laying, in 
cycle i, for mosquito starting cycle i with malaria status m and biopesticide status l 
i,m,l l > 0 
Probability of dying from action of biopesticide between biting host and laying, in 
cycle i, for mosquito starting cycle i with malaria status m and biopesticide status 0 
and acquiring a new biopesticide infection during the cycle 
i,m,0  
Largest integer less than x x   Cost of resistance has not been used for the analysis in the current paper, but is an important 
element of previous analyses conducted with the model, focussing on theoretical chemical LLAs 
([8]) 
 
Appendix B 
 
Derivation of the population model 
The primary definitions for the PM are given in the main text and Table 3. Full supporting 
details are given below and in Table 6. 
 
The proportion of the population having genotype g at the start of period n is calculated as the 
part of the population with that genotype at the beginning of the period, expressed as a 
proportion of the initial population size, divided by the total population size at the start of 
period n, likewise expressed as a proportion of the initial population size. 
,
,
g n
g n
n
Y
G
W

 
The part of the population having genotype g at the start of period n, ,g nY , is calculated as the 
part of the population with that genotype at the beginning of the previous period multiplied by 
the proportion of such mosquitoes surviving to the end of the period, plus the new adults 
recruited at the start of period n with genotype g, all expressed as a proportion of the initial 
population size. 2,1 2,1Y G  and 3,1 3,1Y G .  
1,1 2,1 3,11Y Y Y    and 
, , 1 , 1 ,g n g n g n g nY Y P KN      with n>1 
 
The three genotypes map to the two phenotypes, resistant, j=2, and non-resistant, j=1, as 
follows; 
 
1 1
2 1
3 2
g j
g j d
g j
  
   
    
 
The proportion, ,g nP , of mosquitoes starting period n with genotype g which survive to the start 
of period n+1, is calculated as the sum of survival probabilities for mosquitoes with the 
phenotype generated by genotype g, in each age group multiplied by the proportion of the 
mosquitoes with genotype g in that age group. 
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nW , the total population size in period n, expressed as a proportion of the initial population 
size, is calculated as the total of population sizes for each genotype, expressed on the same 
basis. 
3,
1
n g n
g
W Y

 
 
The proportion, ,g nN , of new adults joining the population with a given phenotype in a given 
period is equal to the proportion of the genotype among the eggs giving rise to the new adults.  
, ,g n g nN E     n > Φ 
, ,1g n gN E    n § Φ 
The average number of bites per mosquito in the population, nM , is calculated as the sum of 
the totals for each genotype of the number of infectious bites per mosquito in each age category 
for mosquitoes with the applicable phenotype, multiplied by the proportion of mosquitoes with 
that genotype falling into each age category.    
3
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The PM starts with a sub-population age-structure for each genotype within the whole 
population, ,1,g iC , reflecting the survival values generated in the FCM for mosquitoes subject 
to the appropriate treatment regime, with any relevant cost-of-resistance parameters.  
 
In subsequent periods, the proportion of genotype g mosquitoes in age cycle 1 is calculated as 
the proportion of new adults with genotype g multiplied by the total number of new adults 
expressed as a proportion of the initial population size, divided by the total mosquitoes with 
genotype g at the start of period n, also expressed as a proportion of the initial population size 
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      n > 1 
For older age classes, the proportion of genotype g mosquitoes in each age cycle, , ,g n iC  is 
calculated as the proportion of mosquitoes with genotype g falling into the preceding age 
category multiplied by the relevant survival probability, divided by the total mosquitoes with 
genotype g at the start of period n 
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         1< i    n>1 
The proportion Eg,n, of eggs produced in period n which have genotype g, is calculated as the 
number of eggs produced in period n with genotype g, divided by the total number of eggs 
produced in period n. 
,
,
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g n
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The numbers of eggs produced with each of the three possible genotypes, Bg,n, are calculated 
using the appropriate number of eggs per female for relevant phenotypes and ages, using the 
appropriate proportion of each genotype in the population to calculate the relevant allele 
contribution from the female population, multiplied by allele proportions appropriate to the 
male population in the period of mating for each female age class.  
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The proportions, 1,nA  and 2,nA  of susceptible and resistant alleles available from the male 
population in period n is calculated based on the proportion of newly hatched males with each 
genotype, and any relative fitness adjustments applied to different phenotypes. Male genotypes 
for matings prior to the start of the modelled time period are assumed to be consistent with 
those in the population in the first modelled period, so , ,1    1j n jA A n   
 
1, 2 2, 1 1, 1 1, 2 2, 3 3,(0.5 )/( )n n n n n nA f N f N f N f N f N     
 
2, 2 2, 3 3, 1 1, 2 2, 3 3,(0.5 )/( )n n n n n nA f N f N f N f N f N     
 
Table 6 
Variable or Parameter 
 
Symbol Comments & 
Constraints 
Number of mosquito age classes included in analysis λ  
Mosquito age (gonotrophic cycles) i 0 < i § λ 
Phenotype j   susceptible j = 1 
  resistant j = 2 
Probability of survival for mosquitoes with phenotype j,  to age i+1 from age i     
(i>=1) 
Sj,i values from FCM 
Mosquitoes with genotype g at start of period n as percentage of initial population Ygn  
Allele a as proportion alleles contributed by male population in period n Aa,n s      a = 1 
r      a = 2 
Proportion of mosquitoes with genotype g which survive from start of period n to 
start of period  n+1 
Pg,n  
Proportion of mosquitoes with genotype g which are age i at start of period n Cg,n,i  
Average number of eggs laid by females of phenotype j, aged i Fj,i values from FCM 
Total number of eggs with genotype g laid in period n Bg,n  
Proportion of all eggs laid in period n having genotype g Eg,n  
   
Proportion of all new adults having genotype g at start of period n Ng,n N2,1=G2,1 
Fitness factor for males with genotype g fg  
Average number of infectious bites per mosquito of phenotype j aged i in period n Ij,i values from FCM 
New adults as % initial population  K values from FCM 
 
